Zabeer Bhatti, MD
Cardiovascular Disease · Lawrenceville, NJNPI 1619354701
Payments from drug & device makers
What this record shows
This record is dominated by grants: $42,000 of the $54,906 with a category attached, or 76.5%. Medtronic accounts for 78.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $25,300 and has fallen 87.9% since, to $3,054 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 282 payments — averaging $194.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$43K
- Abbott$8K
- Biosense Webster, Inc.$2K
- Biotronik Inc.$1K
- Boston Scientific$493
- Astellas Pharma US Inc$111
- plus $130 from 4 others
What the payments were for
- Grants$42,00076%
- Travel & lodging$1,3552%
- Food & beverage$10,60319%
- Education$9482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $42,879 |
| Abbott | 173 | $8,364 |
| Biosense Webster, Inc. | 38 | $1,523 |
| Biotronik Inc. | 37 | $1,407 |
| Boston Scientific | 11 | $493 |
| Astellas Pharma US Inc | 2 | $111 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| Johnson & Johnson | 1 | $34 |
| Philips North America LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$2,209
- Carto 3$827
- ENSITE$535
- BioMonitor$394
- AMVIA EDGE$280
- AMPLATZER AMULET$277
- ADVISOR$216
- NA$209
- HeartMate 3 Left Ventricular Assist Device$204
- HeartMate 3 Left Ventricular Dev$195
- QUADRA ASSURA$187
- VANTAGEVIEW$176
- ACCENT$170
- COBALT DR MRI SURESCAN$164
- Farapulse$125
- CARDIOBLATE CRYOFLEX$121
- Agilis HisPro$121
- AZURE XT DR MRI SURESCAN$120
How this compares
$54,906 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $26,519 |
| Amiodarone Hcl | 30 | $4,757 |
| Dofetilide | 24 | $3,611 |
| Metoprolol Succinate | 18 | $311 |
| Carvedilol | 16 | $113 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Lawrenceville
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
- Fadi ChaabanWest Orange$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.